TRISULFA G LIQ DIN 00391492
Health Canada record
| Active ingredient(s) | SULFATHIAZOLE 45 MG; SULFAPYRIDINE 20 MG; SULFAMETHAZINE 45 MG |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1977 |
| Current status date | 10-Sep-1996 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SULFATHIAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00153605 | SULTRIN TRIPLE SULFA CRM | ORTHO PHARMACEUTICAL, DIVISION OF JANSSEN-ORTHO INC. | Cream | SULFATHIAZOLE 3.42 %; SULFACETAMIDE 2.86 %; SULFANILYLBENZAMIDE 3.7 %; UREA 0.64 % | Cancelled Post Market |
International API supply for SULFATHIAZOLE
0 active FDA Drug Master Files.
Request a quote for TRISULFA G LIQ